跳至主要内容
临床试验/ITMCTR2000003155
ITMCTR2000003155尚未招募未知

A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome

Affiliated Hospital of Shandong University of TCM0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Patients, who were diagnosed with the criteria of essential hypertension, who belonged to the types of upper heat and lower cold syndrome,who after the lifestyle intervention,and diagnosed the upper heat and lower cold syndrome of essential hypertension grade I;
  • (2) In the past 2 weeks, the blood pressure was stable, without the treatment of traditional Chinese medicine or proprietary Chinese medicine, without the treatment of western medicine or after the treatment of western medicine, the blood pressure was still in hypertensive grade 1 patients;
  • (3) aged 18-75 years old;
  • (4) Volunteer to participate in the experiment and sign the informed consent, and cooperate with various investigations and tests.

排除标准

  • 1. secondary hypertension, refractory hypertension, malignant hypertension, acute and subacute hypertension, white coat hypertension and unstable blood pressure;
  • 2. pregnant and lactating women, women of child-bearing age do not agree to use contraceptive measures during the experiment;
  • 3. Have mental illness, can't cooperate very well;
  • 4. confirmed to have serious heart disease, severe neurosis and heart, liver, kidney insufficiency;
  • 5. With severe endocrine, hematopoietic system, liver, kidney and other primary diseases, malignant tumors, mental patients;
  • 6. Uncorrected hyperthyroidism, hypothyroidism; Patients with nephrotic syndrome, diabetes mellitus and acute hepatobiliary disease;
  • 7. people who have suffered from serious cerebrovascular accidents, heart diseases, severe trauma, major surgery and other primary diseases with unstable general conditions and poor prognosis within 6 months;
  • 8. Data were collected on cases of other diseases that were under medical treatment and affected experimental drug observers;
  • 9. those who have participated in clinical trials of other drugs within three months;
  • 10. Other conditions that the researchers considered inappropriate for inclusion were eliminated.

研究者

发起方
Affiliated Hospital of Shandong University of TCM

相似试验

A randomized controlled trial for the clinical... | 临床试验